I believe Schwab gets paid for order flow so might be harder to get good execution. Fidelity does not and has better execution. Schwab used to have some of the best but I believe that changed a few years ago maybe when they bought TDAmeritrade that sold its order flow. I have accounts at both but do not trade a Schwab much for that reason. I had to switch to Fidelity from TD Ameritrade when Schwab bought them because Schwab did not host some of the types of accounts I have.
I had trouble selling at 35 and ended up selling some at 25 and then 30 and sold a little more at 28. I had 38,000 for many years buying in 2020-2021 at 3-5. I’m down to 23,000 shares now and plan to hold but I don’t trust RFK and FDA. I hope we get approval but what if they say it is too expensive? When does everyone think we will get an answer from FDA? I’ll try to check here more regularly.
Market Data 
Markets 
AI
